Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

PPG Coatings Services is the industry leader in protective coating applications, serving customers throughout the United States and around the world. Building on the combined experience of MetoKote Corporation and The Crown Group, PPG Coatings Services can unite three traditions of excellence, joining the high-performance liquid, powder and e-coat protective coatings you expect from PPG with the industry-leading application services you've come to know and trust from our two legacy companies.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

Jiangxi Yuankang Silicon Industry Technology Co., Ltd., established on 2012-02-04, Business scope includes triphenylchloromethane,hydrochloric acid,sulfuric acid,Production and sales of silicone materials including but not limited to hydrogen-containing silicone oil.Heptamethyltrisiloxane,Octamethyltrisiloxane,Production and sales of tetramethyldihydrodisiloxane,Technical Services.(The license is valid until2024year9moon25day)

Roussel UCLAF.

Zhejiang Huahai Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. It also integrates and intermediates formulations such as Active Pharmaceutical Ingredients. Its products include Irbesartan and Hydrochlorothiazide Tablet, Paroxetine Hydrochloride Tablet and Irbesartan Tablet. The company was founded in 1989 and is headquartered in Zhejiang, China.

Linhai Huanan Chemical Co., Ltd., established on 1998-03-06, Business scope includes organic intermediates(Does not contain licensed items and national prohibitions,limit,Eliminated items)manufacture,Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Changchun Baichun Hecheng Pharmaceutical Technology Co., Ltd., established on 2014-10-28, The business scope includes pharmaceutical preparations,Health products,Biological product,Diagnostic reagents,chemistry medicine,Pharmaceutical Intermediates,Chemical Products(The above items do not contain hazardous chemicals)technology research and development,technical consulting,Technical Services,technology transfer;chemistry medicine,Pharmaceutical Intermediates,Chemical Products(The above items do not contain hazardous chemicals),Sales of experimental equipment and related consumables;Import and export,Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)*

Manufactures petrochemicals, pharmaceuticals, functional materials and plastic-based products

Manufactures and sells chemicals

Chugoku Kayaku Co., Ltd. is a company headquartered in Kure, Japan. The firm manufactures and sells industrial fire products, medical products and refreshing beverages & processes fire and hazardous materials. It was founded in 1947.

Zhejiang Huahai Pharmaceutical Co., Ltd. Shanghai Branch, established on 2004-04-22, The scope of business includes import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Imperial Chemical Industries (ICI) was a British chemical company and was, for much of its history, the largest manufacturer in Britain. It was formed by the merger of leading British chemical companies in 1926. Its headquarters were at Millbank in London, and it was a constituent of the FT 30 and later the FTSE 100 indices.

Sanko is a manufacturer and seller of press products, mechatronics products, and plastic products. Their product and technology categories include press products, plastic products, and mechanism development design proposals. Their equipment lists such as press product mass production equipment, mass production equipment for plastic products, and mold manufacturing equipment.

Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of its separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.